[ad_1] RT @OphthTimes: . @REGENXBIO announces dosing of first patient in phase II ALTITUDE™ trial of RGX-314 for the diabetic retinopathy treatmen… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] For COVID-19, mRNA vaccines have sprinted to approval. Historically, #retina played an important role in #RNA #therapy development, with the first approved ASO in 1998. We just published on potential RNA therapies for #AMD, #diabeticretinopathy & IRDs… https://t.co/S9TpaLYBsg [ad_2] Source by Thomas Ciulla, MD, …
[ad_1]
Interviewed by @OTEurope on our study of #diabetic macular edema, a leading cause of #vision loss. Patients who miss #treatment during this pandemic may lose vision, as current agents require frequent treatment in the first year for best outcomes.
#retina
https://t.co/KeZRL2VNQm
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Our study highlighted in @RetinalPhys – #Suprachoroidal delivery is of interest given #clinicaltrials of corticosteroid in #macular edema, tyrosine kinase inhibitor in wet #AMD, #genetherapy in wet AMD & #diabetic retinopathy, viral nanoparticle conjugates in choroidal melanoma: https://t.co/6po57PW5ux [ad_2] Source by Thomas Ciulla, MD, …
[ad_1] Recently published on a leading cause of #vision loss. #Diabetic macular edema treatment burden remains a significant barrier to meaningfully positive real world outcomes. Longer acting and more effective #treatments are needed… #retina #diabetes https://t.co/BMsesiBPCL [ad_2] Source by Thomas Ciulla, MD, MBA Return to …
[ad_1]
Honored to be listed here and thankful for those patients, colleagues & mentors who inspire us… https://t.co/ZqzoqzpO2Z
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Just published on suprachoroidal drug delivery: “Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders” https://t.co/fyTjYAo5gw #eyes #ophthalmology #retina #macula #clinicalresearch #GeneTherapy #biotech https://t.co/EIUMer01Fj [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Exciting news from Indianapolis-based Biotech, Eli Lilly… https://t.co/3qTHNQkfjs [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Lean Six Sigma concepts can reduce waste and enhance patient care… https://t.co/Tfe0ZwBkdZ
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Pleased to work with Vestrum on clinical data analytics… https://t.co/4uIFiCI2NM https://t.co/2KDXdfUQba [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.